Beam Therapeutics Inc
BEAM
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.57B
Close$
$-25.93
205.1% downside
Current Fair Value
205.1% downsideOvervalued by 205.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.57 Billion |
|---|---|
| Enterprise Value | $2.59 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.81 |
| Beta | 2.23 |
| Outstanding Shares | 104,326,669 |
Return
| Return on Equity | -8.00% |
|---|---|
| Return on Assets | -6.16% |
| Return on Invested Capital | -8.39% |
Valuation & Multiples
| P/E Ratio | -30.43 |
|---|---|
| PEG | -152.67 |
| Price to Sales | 24.66 |
| Price to Book Ratio | 2.47 |
| Enterprise Value to Revenue | 20.87 |
| Enterprise Value to EBIT | -23.69 |
| Enterprise Value to Net Income | -31 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-1.09
Average shareholder expectationRevenue Estimate
$13.85 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-1.16
Average shareholder expectationRevenue Estimate
$8.75 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3294▼ 19.51% |
|---|---|
| Total Calls | 588,900▲ 1.27% |
| Total Puts | 194,000▼ 36.39% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 105.71%▲ 0.84% |
|---|---|
| Total Invested | $3.78B▲ 46.72% |
| Investors Holding | 286▲ 21.00% |
ESG Score
No data